About QED Therapeutics & BridgeBio Pharma
QED Therapeutics, an affiliate of BridgeBio Pharma , focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-dri...
Bridge Bio Pharma
28 days ago